Searchable abstracts of presentations at key conferences in endocrinology

ea0029p998 | Growth hormone IGF axis - basic | ICEECE2012

Quality of life in adult patients with GH deficiency and neurosecretory dysfunction at the end of GH therapy

Quitmann J. , Kammerer U. , Bullinger M. , Schofl C. , Dorr H.

GH is used primarily to increase adult height in short children with GHD/NSD with little knowledge about the impact of GH on health-related quality of life (HRQoL). Therefore this study was carried out to evaluate HRQoL in adult patients with childhood onset GHD/NSD at the end of GH therapy.HrQoL was measured by patient self-report using two generic questionnaires, SF36 and NHP. Patient data were compared to representative norm data. Clinical data as wel...

ea0009oc11 | Oral Communication 2: Reproduction and growth | BES2005

A defect in the DHEA-DHEAS shuttle defines a novel cause of polycystic ovary syndrome

Arlt W , Hammer F , Filko D , Chalder S , Hughes B , Sanning P , Schofl C , Stewart P

Dehydroepiandrosterone (DHEA) is the crucial androgen precursor and hyperandrogenaemia is a major feature in Polycystic Ovary Syndrome (PCOS). DHEA sulfate (DHEAS) is generated from DHEA by DHEA sulfotransferase (SULT2A1) activity. The conversion of DHEAS to DHEA by steroid sulfatase has been reported to be of minor significance in human adults and only desulfated DHEA can be converted toward androgens. Therefore, SULT2A1 activity represents the rate-limiting step regulating t...